nephrosclerosis

1. In malignant nephrosclerosis, the kidney demonstrates focal small hemorrhages.
   恶性肾硬化时，肾脏出现局灶性出血。
2. The clinical study of plasma renin activity and aldosterone in diagnosing malignant hypertensive arteriolar nephrosclerosis
   血浆肾素、醛固酮在恶性高血压性小动脉性肾硬化诊断中的临床研究
3. A Study on Risk Factors of Benign Arteriolar Nephrosclerosis in Elderly Patients with Essential Hypertension
   老年高血压病患者良性小动脉性肾硬化症危险因素分析
4. It is not uncommon to see lymphocytes accompany just about any chronic renal disease: glomerulonephritis, nephrosclerosis, pyelonephritis.
   在任何慢性肾脏疾病，如肾小球肾炎、肾硬化或肾盂肾炎等，淋巴细胞都很常见。
5. Conclusions: abnormalities of fibrinolytic activity and D D level play an important role in hypertensive arteriolar nephrosclerosis and can be used as indicator for early diagnosis.
   结论：纤溶活性和血、尿d二聚体水平变化在高血压肾小动脉硬化的发生发展中具有重要作用，可作为早期诊断的依据。
6. Objective To study the diagnostic value of plasma renin activity ( PRA) and aldosterone ( ALD) in diagnosing malignant hypertensive arteriolar nephrosclerosis.
   目的探讨血浆肾素活性（PRA）及醛固酮（ALD）水平在恶性高血压性小动脉性肾硬化诊断中的价值。
7. Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
   目的：观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
8. Objective To investigate the clinical and pathological characteristics of patients with clinically presumed hypertensive nephrosclerosis ( HN).
   目的探讨拟诊高血压肾硬化（HN）患者的临床特征，以期提高对良性肾小动脉硬化症（BN）及类似疾病的认识。
9. The Relation between TIMP-1 and Hypertension Nephrosclerosis Effect of losartan on hemorrheology of hypertensive arteriolar nephrosclerosis
   高血压性肾硬化患者血清中TIMP-1含量变化及意义氯沙坦对原发性高血压良性小动脉肾硬化血液流变性的影响
10. Conclusion Telmisartan has better efficacy than amlodipine in treatment of renal damage caused by benign arteriolar nephrosclerosis.
    结论替米沙坦对良性小动脉性肾硬化所致肾损害的改善较氨氯地平为好。
11. Methods: Chronic nephrosclerosis model rats induced by repeated intraperitoneal injection of puromycin were randomly divided into the model group, AAM group and Irbesartan ( an antagonist of angiotensin) group.
    方法：采用大鼠慢性嘌呤霉素肾硬化模型，随机分为模型组，黄芪当归合剂治疗组（简称中药治疗组），血管紧张素受体拮抗剂（Irbesartan）治疗组（简称AT1RA组）。
12. A study on the relationship between changes of fibrinolytic activity, D-dimer level and benign arteriolar nephrosclerosis due to primary hypertention in the elderly
    纤溶活性及D-二聚体变化与老年高血压肾损害关系的研究
13. Effect of Astragalus-Angelica Mixture on Osteopontin Expression in Rats with Chronic Nephrosclerosis
    黄芪当归合剂对大鼠慢性肾硬化中骨桥蛋白表达的影响
14. Relationship between polymorphism of insulin receptor gene Exon 17 with hypertensive nephrosclerosis and renal hypertension
    高血压肾损害与肾实质性高血压胰岛素受体基因第17外显子多态性研究
15. In the motherland medicine, there is no exact name of disease corresponding to the hypertension nephrosclerosis.
    在祖国医学中，并无确切的病名与高血压肾损害相对应。

noun

1. kidney disease that is usually associated with hypertension

   Synonym:    nephroangiosclerosis